Effects of barbiturates on the expression of the inducible nitric oxide synthase in vascular smooth muscle

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 6, 1997, Pages 802-810

  Kessler, Paul ^a   Kronemann, Nicola ^a   Hecker, Markus ^a   Busse, Rudi ^a   Schini Kerth, Valérie B ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Anesthetics, intravenous; Barbiturates, thiopental; Inducible nitric oxide synthase; Nuclear factor B.; Vascular smooth muscle cells

Indexed keywords

BARBITURIC ACID DERIVATIVE; HEXOBARBITAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; METHOHEXITAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PENTOBARBITAL; PHENOBARBITAL; PHENYLEPHRINE; THIOPENTAL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CAROTID ARTERY; DRUG POTENTIATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HYPOTENSION; IMMUNOBLOTTING; INTRAVENOUS ANESTHESIA; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SEPTIC SHOCK; VASCULAR SMOOTH MUSCLE;

ANESTHETICS, INTRAVENOUS; ANIMALS; BARBITURATES; INTERLEUKIN-1; MALE; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RATS; RATS, INBRED WKY; RNA, MESSENGER; THIOPENTAL;

EID: 0031406570     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199712000-00016     Document Type: Article

References (58)

1. 2+-dependently converts L-arginine into an activator of soluble guanylate cyclase. Biochem Biophys Res Commun 1989;164:678-85.
2. Sessa CM. The nitric oxide synthase family of proteins. J Vasc Res 1994;31:131-43.
3. Förstermann U, Schmidt HHHW, Pollock JS, et al. Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochem Pharmacol 1991;42:1849-57.
4. Busse R, Mülsch A. Calcium-dependent nitric oxide synthase in endothelial cytosol is mediated by calmodulin. FEBS Lett 1990; 265:133-6.
5. Busse R, Mülsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 1990;275:87-90.
6. Xie QW, Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukoc Biol 1994;56:576-82.
7. Kilbourn RG, Belloni P. Endothelial cell production of nitrogen oxides in responses to Interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 1990;82:772-6.
8. Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A 1985;82:7738-42.
9. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kB/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269:4705-8.
10. Lorsbach CJ, Murphy WJ, Lowenstein CJ, Snyder SH, Russel SW. Expression of nitrite oxide synthase gene in mouse macrophages activated for tumor cell killing: molecular basis for the synergy between interferon-γ and lipopolysaccharide. J Biol Chem 1993; 268:1908-13.
11. Imai T, Hirata Y, Kanno K, Muramo F. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J Clin Invest 1994;93:543-9.
12. Hirokawa K, O'Shaughnessy K, Moore K, Ramrakha P, Wilkins MR. Induction of nitric oxide synthase in cultured vascular smooth muscle cells: the role of cyclic AMP. Br J Pharmacol 1994;112:396-402.
13. Schini-Kerth VB, Fisslthaler B, Busse R. CGRP enhances induction of NO synthase in vascular smooth muscle cells via a cAMP-dependent mechanism. Am J Physiol 1994;267:H2483-90.
14. Shibano T, Vanhoutte P. Induction of NO production by TNF-α and lipopolysaccharide in porcine coronary arteries without endothelium [Abstract]. Am J Physiol 1993;264:H403-7.
15. Johns RA, Tichotsky MS, Muro MB, Spaeth JP, Le Cras TD, Rengasamy A. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation. Anesthesiology 1995;83:823-34.
16. Lischke V, Busse R, Hecker M. Selective inhibition by barbiturates of the synthesis of endothelium-derived hyperpolarizing factor in the rabbit carotid artery. Br J Pharmacol 1995;115:969-74.
17. Hart JL, Jing M, Bina S, Freas W, Van Dyke RA, Muldoon SM. Effects of halothane on EDRF/cGMP-mediated vascular smooth muscle relaxations. Anesthesiology 1993;79:323-31.
18. Uggeri MJ, Proctor GJ, Johns RA. Halothane, enflurane, and isoflurane attenuate both receptor- and non-receptor-mediated EDRF production in the rat thoracic aorta. Anesthesiology 1992;76:1012-7.
19. Toda H, Nakamura K, Hatano Y, Nishiwada M, Kakuyama M. Halothane and isoflurane inhibit endothelium-dependent relaxation elicited by acetylcholine. Anesth Analg 1992;75:198-203.
20. Biaise G, To Q, Parent M, Lagarde B, Asenjo F, Sauve R. Does halothane interfere with the release, action, or stability of endothelium-derived relaxing factor/nitric oxide? Anesthesiology 1994;80:417-26.
21. Terasako K, Nakamura K, Toda H, Kakuyama M, Hatano Y, Mori K. Barbiturates inhibit endothelium-dependent and independent relaxations mediated by cyclic GMP. Anesth Analg 1994;78:823-30.
22. Gerkens JF. Barbiturate inhibition of endothelium-dependent dilatation of blood- and Krebs-perfused rat tail arteries. Eur J Pharmacol 1987;134:293-301.
23. Lischke V, Busse R, Hecker M. Inhalation anesthetics inhibit the release of endothelium-derived hyperpolarizing factor in the rabbit carotid artery. Anesthesiology 1995;83:574-82.
24. Tobin JR, Martin LD, Breslow MJ, Traystman RJ. Selective anesthetic inhibition of brain nitric oxide synthase. Anesthesiology 1994;81:1264-9.
25. Rengasamy A, Ravichandran LV, Reikersdorfer CG, Johns RA. Inhalational anesthetics do not alter nitric oxide synthase activity. J Pharmacol Exp Ther 1995;273:599-604.
26. Tagliente TM. Halothane effects on rat brain nitric oxide synthase enzyme kinetics [Abstract]. Anesthesiology 1994;81:A806.
27. Zuo Z, Tichotsky A, Johns RA. Halothane and isoflurane inhibit vasodilation due to constitutive but not inducible nitric oxide synthase. Anesthesiology 1996;84:1156-65.
28. Chomcsynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
29. Hecker M, Preiss C, Schini-Kerth VB. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kB, CREB and C/EBPβ. Br J Pharmacol 1997; 120:1067-74.
30. Koide M, Kawahara Y, Nakayama I, Tsuda T, Yokoyama M. Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells: synergism with the induction elicited by inflammatory cytokines. J Biol Chem 1993; 268:24959-66.
31. Mac Naul KL, Hutchinson NI. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun 1993;196:1330-4.
32. Beasley D, Schwartz JH, Brenner BM. Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991;87:602-8.
33. Kilbourn RG, Griffith OW. Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 1992;84:827-31.
34. Kim BH, Fulco AJ. Induction by barbiturates of a cytochrome P-450-dependent fatty acid monooxygenase in Bacillus megaterium: relationship between barbiturate structure and inducer activity. Biochem Biophys Res Commun 1983;116:843-50.
35. Hatano Y, Nakamura K, Moriyama S, Mori K, Toda N. The contractile responses of isolated dog cerebral and extracerebral arteries to oxybarbiturates and thiobarbiturates. Anesthesiology 1989;71:80-6.
36. Kress HG, Eberein T, Hörber B, Weis KH. Suppression of neutrophil migration and chemiluminescence is due to the sulphur atom in the thiobarbiturate molecule. Acta Anaesthesiol Scand 1989;33:122-8.
37. Sirsjö A, Söderkvist P, Sundqvist T, Carlsson M, Ost M, Gidlöf A. Different induction mechanisms of mRNA for inducible nitric oxide synthase in rat smooth muscle cells in culture and in aortic strips. FEBS Lett 1994;338:191-6.
38. Marczin N, Papapetropoulos A, Catravas JD. Tyrosine kinase inhibitors suppress endotoxin- and IL-1-induced NO synthesis in aortic smooth muscle cells. Br J Pharmacol 1993;265:H1014-8.
39. Robinson-White AJ, Muldoon SH, Elson L, Collado-Escobar DM. Evidence that barbiturates inhibit antigen-induced responses through interactions with a GTP-binding protein in rat basophilic leukemia (RBL-2H3) cells. Anesthesiology 1990;72:996-1004.
40. Robinson-White AJ, Muldoon SM, Robinson FC. Inhibition of inositol phospholipid hydrolysis in endothelial cells by pentobarbital. Eur J Pharmacol 1989;172:291-303.
41. Duggan PF. Stimulation of calcium uptake of muscle microsomes by phenothiazines and barbiturates. Eur J Pharmacol 1971;13:381-6.
42. Altura BT, Altura BM. Barbiturates and aortic and venous smooth-muscle function. Anesthesiology 1975;43:432-14.
43. Scott-Burden T, Elizondo E, Boulanger CM, Vanhoutte PM. Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells. J Pharmacol Exp Ther 1994;46:274-82.
44. Schini-Kerth VB, Vanhoutte PM. Nitric oxide synthases in vascular cells. Exp Physiol 1995;80:885-905.
45. Sherman MP, Aeberhard EE, Wong VZ, Griscavage JM, Ignarro LJ. Pyrrolidine dithiocarhamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem Biophys Res Commun 1993;191:1301-8.
46. Beasley D, Cohen RA, Levinsky NG. Interleukin-1 inhibits contraction of vascular smooth muscle. J Clin Invest 1989;83:331-5.
47. Schneider F, Schott C, Stoclet JC, Julou-Schaeffer G. L-Arginine induces relaxation of small mesenteric arteries from endotoxin-treated rats. Eur J Pharmacol 1992;211:269-72.
48. Thorin-Trescases N, Hamilton CA, Reid JL, et al. Inducible L-arginine/nitric oxide pathway in human internal mammary artery and saphenous vein. Am J Physiol 1995;268:H1122-32.
49. Beasley D, Eldridge M. Interleukin-1β and tumor necrosis factor-α synergistically induce NO synthase in rat vascular smooth muscle cells. Am J Physiol 1994;266:R1197-203.
50. French JF, Lambert LE, Dage RC. Nitric oxide synthase inhibitors inhibit interleukin-1B-induced depression of vascular smooth muscle. J Pharmacol Exp Ther 1991;259:260-4.
51. Thiemermann C, Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 1990;182:591-5.
52. Becker KE. Plasma level of thiopental necessary to anesthesia. Anesthesiology 1978;49:192-6.
53. Burch PG, Stanski DR. The role of metabolism and protein binding in thiopental anesthesia. Anesthesiology 1983;58:146-52.
54. Thiemermann C. The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol 1994;28:45-79.
55. Ochoa JB, Udekwu AO, Biliar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991;214: 621-6.
56. Gomez-Jimenez J, Salgado A, Mourelle M, et al. L-Arginine/nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995;23-253-8.
57. Lorente JA, Landin L, de Pablo R, Renes E, Liste D. L-Arginine pathway in sepsis syndrome. Crit Care Med 1993;21:1287-95.
58. Preiser J, Lejeune P, Roman A, et al. Methylene blue administration in septic shock: a clinical trial. Crit Care Med 1995; 23: 259-64.